Final Episode
This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across…
Episode Parent: The Niche Pod
Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi/TakedaUniQure & CSLFog…
Indivior + Opiant, Regeneron + CytomX, Rezo, Provention
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesIndivior + OpiantRegeneron + CytomXRezoPreventionAbout the ShowLife…
Intellia, Regeneron, Viatris + Oyster Point
More CRISPR data, oncology wins, and a new player in ophthalmology Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaRegeneronViatris + Oyster PointAbout the ShowLife Science Today is your…
Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye
Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesSumitovant + MyovantThermo Fisher + Binding Site GroupAstellas…
FDA, AbbVie + DJS, Roche + Hookipa, Kyverna
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more athttps://LifeScienceTodayPodcast.comStory References FDAAbbVie + DJSRoche + HookipaKyvernaAbout…
DICE, Odyssey, Fred Hutch, Merck (MSD)
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesDICEOdysseyFred HutchMerck…
Nested, Cellarity, Replimune, Estralla
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC Find out more athttps://LifeScienceTodayPodcast.comStory…
Eisai + Biogen, Amylyx, Sanofi + Regeneron
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEisai + BiogenAmylyxSanofi + RegeneronAbout the ShowLife Science Today…
Alnylam, Intellia, Third Harmonic, Galvanize
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlnylam, Link 2, Link 3Intellia TherapeuticsThird Harmonic…